MMP9 and cancer: This event drives the sustained activation of the EGFR downstream signaling effectors, including AKT and S6 kinase (S6K), which culminates in the increased expression of MMP9 and the reduced expression of E-cadherin, thus leading to cancer invasion and metastasis [31].